Published: May 27, 2021 18:16:02 | Updated: May 28, 2021 13:08:26
The Directorate General of Drug Administration (DGDA) has given emergency use authorisation to the coronavirus vaccine developed by US drugmaker Pfizer and German biotechnological company BioNTech.
The Directorate General of Health Services announced the decision on Thursday after a review of the data on the vaccine being widely used in the Wester countries, reports bdnews24.com.
This is the fourth COVID-19 vaccine to get emergency use authorisation from Bangladesh.
Japanese speech contest held in city
Momen reiterates proposal for ministerial forum on South-South Cooperation
Bangladesh seeks German support to implement NAP on climate change
Russia thanks Bangladesh for abstaining from UNGA vote on Ukraine war
Earthquake felt in Cox’s Bazar; epicentre in Myanmar
Death-row convict of BDR mutiny dies in Dhaka hospital
Six Covid-19 cases reported in 24 hours
Police helped create investment-friendly environment in country: IGP
© 2024 - All Rights with The Financial Express
